Innate Pharma SA Quarterly Assets in EUR from Q4 2017 to Q4 2023

Taxonomy & unit
ifrs-full: EUR
Summary
Innate Pharma SA quarterly Assets history and growth rate from Q4 2017 to Q4 2023.
  • Innate Pharma SA Assets for the quarter ending December 31, 2023 was €184M, a 11.4% decline year-over-year.
Assets, Quarterly (EUR)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 184M -23.7M -11.4% Dec 31, 2023 20-F 2024-04-04
Q2 2023 199M -81.4M -29% Jun 30, 2023 6-K 2023-09-14
Q4 2022 208M -59.6M -22.3% Dec 31, 2022 20-F 2024-04-04
Q2 2022 280M +14.2M +5.34% Jun 30, 2022 6-K 2022-09-15
Q4 2021 267M -39.9M -13% Dec 31, 2021 20-F 2024-04-04
Q2 2021 266M Jun 30, 2021 6-K 2021-09-15
Q4 2020 307M -93.9M -23.4% Dec 31, 2020 20-F 2023-04-06
Q4 2019 401M -49.9M -11% Dec 31, 2019 20-F 2022-04-04
Q4 2018 451M +196M +76.9% Dec 31, 2018 20-F 2021-04-27
Q4 2017 255M Dec 31, 2017 20-F 2020-04-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.